| 减肥药的基础与药理研究进展 |
| |
| 引用本文： | 曹春嫒,雷帆,邢东明,杜力军.减肥药的基础与药理研究进展[J].亚太传统医药,2005(1). |
| |
| 作者姓名： | 曹春嫒 雷帆 邢东明 杜力军 |
| |
| 作者单位： | 清华大学生物科学与技术系药物药理研究室，清华大学生物科学与技术系药物药理研究室，清华大学生物科学与技术系药物药理研究室，清华大学生物科学与技术系药物药理研究室 北京 100084，北京 100084，北京 100084，北京 100084 |
| |
| 摘 要： | 本文对脂类代谢及目前应用的减肥药品作了简要综述,并描述了脂肪细胞的分化过程。肥胖症患者常伴随糖脂代谢的异常,新一代的抗肥胖药及减肥药不仅能减少脂肪组织的量,还要有助于改善患者的代谢紊乱,具有调节血脂功能中药提取物及其活性单体可能带给人们新的亮点。
|
| 关 键 词： | 减肥药 分化 代谢紊乱 |
heoretic Basis and pharmacological development of the Fat reducing agents |
| |
| Cao Chunai,Lei Fan,Xing Dongming,Du Lijun.heoretic Basis and pharmacological development of the Fat reducing agents[J].Asia-Pacific Traditional Medicine,2005(1). |
| |
| Authors: | Cao Chunai Lei Fan Xing Dongming Du Lijun |
| |
| Abstract: | This article reviews lipid metabolism and current antiobesities, summarizes the process and regulation of adipocyte differentiation. Some substances have the possibility to be new and highly effective antiobesity angents. Since the obese patients always have the problem of metabolic disorder, the new antiobesity agents must not only reduce fat mass but must also correct fat dysfunction and new promising ones may be found in Chinese herbs. |
| |
| Keywords: | antiobesity differentiation dysfunction |
| 本文献已被 CNKI 等数据库收录！ |
